A case of toxic epidermal necrolysis probably due to etoricoxib

This case report describes a rare incidence of etoricoxib-induced toxic epidermal necrolysis (TEN) in a 25-year-old woman. The patient presented with rapidly evolving rashes, initially over the face and upper body but subsequently involving the total body surface area. There was an extensive ulcerat...

Full description

Bibliographic Details
Main Authors: Sayanta Thakur, Sandeep Lahiry
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Journal of Current Research in Scientific Medicine
Subjects:
Online Access:http://www.jcrsmed.org/article.asp?issn=2455-3069;year=2019;volume=5;issue=2;spage=118;epage=121;aulast=Thakur
id doaj-8ce3595d2eb742afba28ef30de9bb87b
record_format Article
spelling doaj-8ce3595d2eb742afba28ef30de9bb87b2020-11-25T02:36:53ZengWolters Kluwer Medknow PublicationsJournal of Current Research in Scientific Medicine2455-30692455-30692019-01-015211812110.4103/jcrsm.jcrsm_22_19A case of toxic epidermal necrolysis probably due to etoricoxibSayanta ThakurSandeep LahiryThis case report describes a rare incidence of etoricoxib-induced toxic epidermal necrolysis (TEN) in a 25-year-old woman. The patient presented with rapidly evolving rashes, initially over the face and upper body but subsequently involving the total body surface area. There was an extensive ulceration of buccal mucosa along with eyelid edema, crusting, and corneal ulceration. Naranjo's and WHO–UMC score for this adverse event was “seven;” hence, causality was “probable.” SCORTEN (severity-of-illness score) was “one” with a predicted mortality of 3.2%. Due to persistent hypotension and risk of impending sepsis, aggressive fluid resuscitation and antibiotics were initiated. Cyclosporine and systemic steroids were added later, following which the patient had a prompt recovery. She was discharged after 28 days of hospitalization. However, etoricoxib-induced TEN is a rare clinical association, with very few previously reported cases.http://www.jcrsmed.org/article.asp?issn=2455-3069;year=2019;volume=5;issue=2;spage=118;epage=121;aulast=Thakuradverse drug reactionetoricoxibtoxic epidermal necrolysis
collection DOAJ
language English
format Article
sources DOAJ
author Sayanta Thakur
Sandeep Lahiry
spellingShingle Sayanta Thakur
Sandeep Lahiry
A case of toxic epidermal necrolysis probably due to etoricoxib
Journal of Current Research in Scientific Medicine
adverse drug reaction
etoricoxib
toxic epidermal necrolysis
author_facet Sayanta Thakur
Sandeep Lahiry
author_sort Sayanta Thakur
title A case of toxic epidermal necrolysis probably due to etoricoxib
title_short A case of toxic epidermal necrolysis probably due to etoricoxib
title_full A case of toxic epidermal necrolysis probably due to etoricoxib
title_fullStr A case of toxic epidermal necrolysis probably due to etoricoxib
title_full_unstemmed A case of toxic epidermal necrolysis probably due to etoricoxib
title_sort case of toxic epidermal necrolysis probably due to etoricoxib
publisher Wolters Kluwer Medknow Publications
series Journal of Current Research in Scientific Medicine
issn 2455-3069
2455-3069
publishDate 2019-01-01
description This case report describes a rare incidence of etoricoxib-induced toxic epidermal necrolysis (TEN) in a 25-year-old woman. The patient presented with rapidly evolving rashes, initially over the face and upper body but subsequently involving the total body surface area. There was an extensive ulceration of buccal mucosa along with eyelid edema, crusting, and corneal ulceration. Naranjo's and WHO–UMC score for this adverse event was “seven;” hence, causality was “probable.” SCORTEN (severity-of-illness score) was “one” with a predicted mortality of 3.2%. Due to persistent hypotension and risk of impending sepsis, aggressive fluid resuscitation and antibiotics were initiated. Cyclosporine and systemic steroids were added later, following which the patient had a prompt recovery. She was discharged after 28 days of hospitalization. However, etoricoxib-induced TEN is a rare clinical association, with very few previously reported cases.
topic adverse drug reaction
etoricoxib
toxic epidermal necrolysis
url http://www.jcrsmed.org/article.asp?issn=2455-3069;year=2019;volume=5;issue=2;spage=118;epage=121;aulast=Thakur
work_keys_str_mv AT sayantathakur acaseoftoxicepidermalnecrolysisprobablyduetoetoricoxib
AT sandeeplahiry acaseoftoxicepidermalnecrolysisprobablyduetoetoricoxib
AT sayantathakur caseoftoxicepidermalnecrolysisprobablyduetoetoricoxib
AT sandeeplahiry caseoftoxicepidermalnecrolysisprobablyduetoetoricoxib
_version_ 1724798193161469952